Pharmaceuticals for Leavenworth CMOP

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 is seeking to procure nine different pharmaceutical products for the Leavenworth CMOP (Consolidated Mail Outpatient Pharmacy) facility. The solicitation (36C77025Q0173) covers medications including Nitroglycerin ointment, Nebivolol tablets, Ondansetron oral disintegrating tablets, Prednisone tablets, Pyridostigmine Bromide tablets, and Pioglitazone HCL tablets in various strengths and packaging quantities. Vendors must submit a comprehensive quote package that includes SF1449, a price schedule, state wholesale distributor license, and Buy American Act certificate. Potential contractors are required to verify compliance with the Drug Supply Chain Security Act and submit all materials via email to Contracting Officer Kelley Cunningham. The solicitation is scheduled to be issued on 3/14/2025, with responses due by 3/25/2025, and requires a 10-day delivery timeframe after receipt of order.

The contract is designated as a total small business set-aside, classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and product service code 6505 (Drugs and Biologicals). While specific award values are not disclosed in the pre-solicitation notice, the procurement appears to be focused on a precise pharmaceutical supply requirement for the VA medical facility. Potential bidders must be prepared to meet specific regulatory compliance standards, including possessing a valid state wholesale distributor license and demonstrating adherence to federal procurement guidelines. The solicitation targets small businesses capable of supplying pharmaceutical products with strict delivery and quality specifications. Vendors should carefully review the full solicitation documentation to ensure complete understanding of the procurement requirements and prepare a comprehensive and compliant response.